How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Energy and Power · Forecast 2027–2033
Industrial Radioactive Source Market
- By Source Type: Gamma Sources, Beta Sources, Neutron Sources, Alpha Sources
- By Radioisotope: Cobalt-60, Cesium-137, Iridium-192, Americium-241, Strontium-90
- By Application: Radiography and Non-Destructive Testing, Level and Density Measurement, Sterilization and Disinfection, Tracer Applications, Well Logging
- By Industry End-Use: Oil and Gas, Healthcare and Medical, Manufacturing and Industrial, Food and Agriculture, Research and Development
- By Form Factor: Sealed Sources, Unsealed Sources
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Gamma Sources leads By Source Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Industrial Radioactive Source Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Source Type 4
Radioisotope 5
Application 5
Industry End-Use 5
Form Factor 2
Companies profiled
Eckert & Ziegler AG
Nordion (a division of Sotera Health)
QSA Global
Inc. (a division of Mirion Technologies)
Mirion Technologies Inc.
Amersham plc (part of GE Healthcare)
Isotope Products Laboratories (IPL)
Bhabha Atomic Research Centre (BARC)
Nuclear Fields Inc.
Thermo Fisher Scientific Inc.
Lantheus Medical Imaging Inc.
China Isotope & Radiation Corporation (CIRC)
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Eckert & Ziegler AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Nordion (a division of Sotera Health)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →QSA Global
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Inc. (a division of Mirion Technologies)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Mirion Technologies Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Amersham plc (part of GE Healthcare)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Isotope Products Laboratories (IPL)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Bhabha Atomic Research Centre (BARC)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nuclear Fields Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Thermo Fisher Scientific Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Lantheus Medical Imaging Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →China Isotope & Radiation Corporation (CIRC)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Nordion (Canada)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Radiation Technology Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Nordion (USA)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Nordion (Europe)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,438M by 2033 · 4.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Gamma Sources55.7
- Beta Sources15.4
- Neutron Sources15.8
- Alpha Sources13.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$552.1M → $720.6M · 3.4%
Europe$384.8M → $573.0M · 5.1%
Asia Pacific$351.3M → $478.3M · 3.9%
Latin America$217.5M → $320.7M · 5.0%
Middle East and Africa$167.3M → $234.8M · 4.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.772026
4.782027
4.802028
4.802029
4.812030
4.842031
4.852032
4.862033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Eckert & Ziegler AG21.4
- Nordion (a division of Sotera Health)21.9
- QSA Global7.0
- Inc. (a division of Mirion Technologies)6.5
- Mirion Technologies Inc.7.1
- Amersham plc (part of GE Healthcare)8.0
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Source Type26.8%
Radioisotope19.7%
Application21.8%
Industry End-Use11.9%
Form Factor19.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.0
- Europe24.6
- Asia Pacific20.6
- Latin America13.8
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Eckert & Ziegler AG | 96 | 96 | 87 | 97 | 78 | 81 | 89 |
| Nordion (a division of Sotera Health) | 92 | 80 | 74 | 73 | 80 | 91 | 82 |
| QSA Global | 85 | 66 | 67 | 86 | 85 | 68 | 76 |
| Inc. (a division of Mirion Technologies) | 73 | 75 | 80 | 67 | 75 | 58 | 71 |
| Mirion Technologies Inc. | 56 | 53 | 72 | 65 | 53 | 64 | 61 |
| Amersham plc (part of GE Healthcare) | 68 | 48 | 61 | 48 | 51 | 51 | 55 |
| Isotope Products Laboratories (IPL) | 62 | 54 | 66 | 50 | 60 | 63 | 59 |
| Bhabha Atomic Research Centre (BARC) | 55 | 39 | 41 | 60 | 40 | 50 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Eckert & Ziegler AG
- Nordion (a division of Sotera Health)
- QSA Global
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Eckert & Ziegler AG | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Nordion (a division of Sotera Health) | ◐ | ◐ | ✓ | − | ✓ | ✓ |
| QSA Global | ✓ | − | ◐ | ✓ | ✓ | ◐ |
| Inc. (a division of Mirion Technologies) | ✓ | ✓ | ◐ | − | ✓ | ◐ |
| Mirion Technologies Inc. | ◐ | − | ◐ | − | − | ◐ |
| Amersham plc (part of GE Healthcare) | ◐ | − | − | − | − | − |
| Isotope Products Laboratories (IPL) | − | ◐ | ◐ | − | ◐ | ◐ |
| Bhabha Atomic Research Centre (BARC) | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Eckert & Ziegler AG89
2Nordion (a division of Sotera Health)82
3QSA Global76
4Inc. (a division of Mirion Technologies)71
5Mirion Technologies Inc.61
6Isotope Products Laboratories (IPL)59
7Amersham plc (part of GE Healthcare)55
8Bhabha Atomic Research Centre (BARC)48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Eckert & Ziegler AGNordion (a division of Sotera Health)
Challenger2
Strong scale, closing on the leaders.
QSA GlobalInc. (a division of Mirion Technologies)
Contender2
Focused players with pockets of strength.
Mirion Technologies Inc.Isotope Products Laboratories (IPL)
Niche2
Specialists in a single segment or region.
Amersham plc (part of GE Healthcare)Bhabha Atomic Research Centre (BARC)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Source Type in North America, then scale across Industrial Radioactive Source Market — a $86M beachhead inside a $1.40B market.
Beachhead (SOM)$86Mobtainable near-term
Serviceable (SAM)$555Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Gamma Sources
Best fit — highest urgency & budget in Source Type.
Economic buyer80 fit
Beta Sources
Strong fit — clear ROI and a fast path to value.
End user66 fit
Neutron Sources
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Radioisotope & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel27%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Source Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Industrial Radioactive Source Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified26%
Evaluation12%
Closed-won7%
$9.9KCAC
$45KLTV
4.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Industrial Radioactive Source Market is a durable-growth opportunity — $7.26B by 2033, compounding at 6.5%.
TAM · 2025$4.39Btoday
TAM · 2033$7.26Bforecast
CAGR6.5%2027–2033
Cumulative$51.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.26BTotal addressable market
SAM$2.60BServiceable available market
SOM$501MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.5% CAGR
Demand compounds through 2033, outpacing GDP across Source Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.26BLarge & growingTAM by 2033 at 6.5% CAGR
$2.60BServiceable nowreachable with today’s model
$501MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.66BBear4.2% CAGR
$7.26BBase6.5% CAGR
$9.29BBull8.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Radioisotope optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Industrial Radioactive Source Market — a $4.34B market by 2033. Plan: grow share from 8.5% to 13.3%.
Market size · 2033$4.34Btotal addressable
Market CAGR4.2%2027–2033
Target share13.3%from 8.5% today
Revenue ambition$577Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.5% | 13.3% | On track |
| Revenue | $376M | $577M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 34.0% | 43.9% | On track |
| Customer retention | 87.7% | 92.9% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Radioisotope capability
A defensible second engine — invest in Radioisotope to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Radioisotope
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $71M capacity & capability investment
- Greenlight bolt-on M&A in Radioisotope
- Authorise North America expansion plan
- Fund R&D program for Source Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Industrial Radioactive Source Market conversation — a $4.24B market you can size, segment and defend in minutes.
Market size · 2033$4.24Btotal opportunity
Growth6.3%CAGR to 2033
Addressable buyers1,544+accounts in scope
Typical ROI5.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source Type
Goal Grow share in Source Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.9×return on cost, year one
< 2 mopayback period
$44K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Eckert & Ziegler AGNordion (a division of Sotera Health)QSA GlobalInc. (a division of Mirion Technologies)Mirion Technologies Inc.Amersham plc (part of GE Healthcare)Isotope Products Laboratories (IPL)Bhabha Atomic Research Centre (BARC)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Industrial Radioactive Source Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Industrial Radioactive Source Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Energy and Power · scroll →Industrial Pump Station Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportIndustrial Propeller Pump Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportIndustrial Primary Lithium Batteries Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportIndustrial Power Units Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportIndustrial Power Transmission Solutions Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportIndustrial Power System Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportIndustrial Power Supply Product Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportIndustrial Power Supply Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportIndustrial Power Products Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportIndustrial Power Plug and Socket Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportIndustrial Power Monitoring System Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportIndustrial Power Modules Market
Market size, share, segmentation and regional forecast.
$752M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.